Prostate cancer: the value of combined urinary T2:ERG and PCA3 testing

L'accès à l'intégralité du contenu de ce site est reservé uniquement aux professionnels de santé disposant d'un compte. Inscrivez-vous gratuitement
Takeaway
  • Combined urinary testing for the 2 prostate cancer (PCa)-associated RNA markers, T2:ERG and PCA3, improved specificity of predicting aggressive PCa compared with prostate-specific antigen (PSA). 
  • 42% of unnecessary prostate biopsies would have been averted by using combined urinary test...